{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:48:30Z","timestamp":1786373310444,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.2215\/cjn.03130314","type":"journal-article","created":{"date-parts":[[2014,9,3]],"date-time":"2014-09-03T01:12:25Z","timestamp":1409706745000},"page":"1965-1973","source":"Crossref","is-referenced-by-count":46,"title":["Decreased Conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 Following Cholecalciferol Therapy in Patients with CKD"],"prefix":"10.2215","volume":"9","author":[{"given":"Jason R.","family":"Stubbs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Nolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20230601","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1021\/bi960658i","article-title":"Human 25-hydroxyvitamin D3-24-hydroxylase, a multicatalytic enzyme.","volume":"35","author":"Beckman","year":"1996","journal-title":"Biochemistry"},{"key":"R2-21-20230601","first-page":"888","article-title":"Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase.","volume":"86","author":"Zehnder","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-21-20230601","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1681\/ASN.V10122465","article-title":"Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in the human kidney.","volume":"10","author":"Zehnder","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R4-21-20230601","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1053\/j.ajkd.2005.02.029","article-title":"Prevalence of calcidiol deficiency in CKD: A cross-sectional study across latitudes in the United States.","volume":"45","author":"LaClair","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R5-21-20230601","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/ndt\/gfl718","article-title":"Mineral metabolism parameters throughout chronic kidney disease stages 1-5\u2014achievement of K\/DOQI target ranges.","volume":"22","author":"Craver","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R6-21-20230601","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"R7-21-20230601","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.M210490200","article-title":"The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency.","volume":"278","author":"Bai","year":"2003","journal-title":"J Biol Chem"},{"key":"R8-21-20230601","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R9-21-20230601","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/ki.2010.168","article-title":"Dysregulation of renal vitamin D metabolism in the uremic rat.","volume":"78","author":"Helvig","year":"2010","journal-title":"Kidney Int"},{"key":"R10-21-20230601","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.2010.313","article-title":"Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.","volume":"78","author":"Hasegawa","year":"2010","journal-title":"Kidney Int"},{"key":"R11-21-20230601","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MNH.0b013e3283477a7b","article-title":"CYP24A1 and kidney disease.","volume":"20","author":"Petkovich","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R12-21-20230601","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/ki.2013.194","article-title":"Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease.","volume":"84","author":"Zhang","year":"2013","journal-title":"Kidney Int"},{"key":"R13-21-20230601","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ki.2012.222","article-title":"Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites.","volume":"82","author":"Dai","year":"2012","journal-title":"Kidney Int"},{"key":"R14-21-20230601","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2265.1980.tb03399.x","article-title":"Vitamin D metabolites and their relationship to azotaemic osteodystrophy.","volume":"13","author":"Mason","year":"1980","journal-title":"Clin Endocrinol (Oxf"},{"key":"R15-21-20230601","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1046\/j.1523-1755.1999.0550031019.x","article-title":"Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure.","volume":"55","author":"Ishimura","year":"1999","journal-title":"Kidney Int"},{"key":"R16-21-20230601","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/ki.2012.193","article-title":"The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease.","volume":"82","author":"Bosworth","year":"2012","journal-title":"Kidney Int"},{"key":"R17-21-20230601","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s00467-013-2493-9","article-title":"Vitamin D bioavailability and catabolism in pediatric chronic kidney disease.","volume":"28","author":"Denburg","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"R18-21-20230601","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R20-21-20230601","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences.","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"R21-21-20230601","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.501","article-title":"Vitamin D levels and patient outcome in chronic kidney disease.","volume":"75","author":"Ravani","year":"2009","journal-title":"Kidney Int"},{"key":"R22-21-20230601","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.2215\/CJN.00910113","article-title":"25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.","volume":"8","author":"Fern\u00e1ndez-Ju\u00e1rez","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R23-21-20230601","doi-asserted-by":"crossref","first-page":"242","DOI":"10.7326\/0003-4819-149-4-200808190-00005","article-title":"Serum 25-hydroxyvitamin D concentrations and risk for hip fractures.","volume":"149","author":"Cauley","year":"2008","journal-title":"Ann Intern Med"},{"key":"R24-21-20230601","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and risk of cardiovascular disease.","volume":"117","author":"Wang","year":"2008","journal-title":"Circulation"},{"key":"R25-21-20230601","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1681\/ASN.2008111157","article-title":"25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification.","volume":"20","author":"de Boer","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R26-21-20230601","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/bmj.281.6242.712","article-title":"Serum concentrations of 24,25-dihydroxy vitamin D in different degrees of chronic renal failure.","volume":"281","author":"Weisman","year":"1980","journal-title":"BMJ"},{"key":"R28-21-20230601","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0009-8981(82)90239-X","article-title":"Measurement of circulating vitamin D in man.","volume":"121","author":"Clemens","year":"1982","journal-title":"Clin Chim Acta"},{"key":"R29-21-20230601","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.annepidem.2007.12.001","article-title":"Vitamin D status: Measurement, interpretation, and clinical application.","volume":"19","author":"Holick","year":"2009","journal-title":"Ann Epidemiol"},{"key":"R30-21-20230601","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1373\/clinchem.2009.139253","article-title":"The D-lemma: To screen or not to screen for 25-hydroxyvitamin D concentrations.","volume":"56","author":"Holick","year":"2010","journal-title":"Clin Chem"},{"key":"R31-21-20230601","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1681\/ASN.2009080815","article-title":"Reduced hepatic synthesis of calcidiol in uremia.","volume":"21","author":"Michaud","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R32-21-20230601","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1124\/mol.111.076356","article-title":"An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway.","volume":"81","author":"Wang","year":"2012","journal-title":"Mol Pharmacol"},{"key":"R33-21-20230601","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1023\/A:1010994022294","article-title":"Optimizing drug development: Strategies to assess drug metabolism\/transporter interaction potential\u2014toward a consensus.","volume":"18","author":"Tucker","year":"2001","journal-title":"Pharm Res"},{"key":"R34-21-20230601","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cyto.2012.05.015","article-title":"Circulating interferon-\u03b3 correlates with 1,25(OH)D and the 1,25(OH)D-to-25(OH)D ratio.","volume":"60","author":"Barker","year":"2012","journal-title":"Cytokine"},{"key":"R35-21-20230601","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jsbmb.2011.05.003","article-title":"The ratio of serum 24,25-dihydroxyvitamin D(3) to 25-hydroxyvitamin D(3) is predictive of 25-hydroxyvitamin D(3) response to vitamin D(3) supplementation.","volume":"126","author":"Wagner","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R36-21-20230601","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jsbmb.2006.12.066","article-title":"Circulating vitamin D3 and 25-hydroxyvitamin D in humans: An important tool to define adequate nutritional vitamin D status.","volume":"103","author":"Hollis","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R37-21-20230601","doi-asserted-by":"crossref","first-page":"13572","DOI":"10.1073\/pnas.241516798","article-title":"Parathyroid hormone regulates 25-hydroxyvitamin D(3)-24-hydroxylase mRNA by altering its stability.","volume":"98","author":"Zierold","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R38-21-20230601","doi-asserted-by":"crossref","first-page":"e86301","DOI":"10.1371\/journal.pone.0086301","article-title":"Reduced renal \u03b1-Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism.","volume":"9","author":"Sakan","year":"2014","journal-title":"PLoS ONE"},{"key":"R39-21-20230601","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI110023","article-title":"Impaired 24,25-dihydroxyvitamin D production in anephric human and pig.","volume":"67","author":"Horst","year":"1981","journal-title":"J Clin Invest"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201411000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:44:38Z","timestamp":1786369478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201411000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.03130314","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}